Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

ClinicalTrials.gov ID: NCT00001118

Public ClinicalTrials.gov record NCT00001118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of T-20, a Fusion Inhibitor, in HIV-1 Infected Children

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the best dose of T-20, a new anti-HIV drug, to treat HIV-infected children. T-20, unlike other anti-HIV medications, lessens the ability of HIV to infect certain cells (T cells) in the body. Doctors hope to better treat HIV by adding T-20 to anti-HIV drug combinations that include 1 or 2 nucleoside reverse transcriptase inhibitors (NRTIs) plus a nonnucleoside reverse transcriptase inhibitor (NNRTI) and/or a protease inhibitor (PI).

Study identification

NCT ID
NCT00001118
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
24 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Dec 2002 (Actual)
Last update posted
Nov 1, 2021

Ends 2002

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla California 920930672 —
Long Beach Memorial (Pediatric) Long Beach California 90801 —
Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles California 900276016 —
UCSF / Moffitt Hosp - Pediatric San Francisco California 941430105 —
Children's Hosp of Washington DC Washington D.C. District of Columbia 200102916 —
Howard Univ Hosp Washington D.C. District of Columbia 20060 —
Univ of Florida Health Science Ctr / Pediatrics Jacksonville Florida 32209 —
Univ of Miami (Pediatric) Miami Florida 33161 —
Tulane Univ / Charity Hosp of New Orleans New Orleans Louisiana 701122699 —
Children's Hosp of Boston Boston Massachusetts 021155724 —
Boston City Hosp / Pediatrics Boston Massachusetts 02118 —
Baystate Med Ctr of Springfield Springfield Massachusetts 01199 —
Univ of Massachusetts Med School Worcester Massachusetts 016550001 —
Children's Hosp of Michigan Detroit Michigan 48201 —
Univ of Medicine & Dentistry of New Jersey / Univ Hosp Newark New Jersey 071032714 —
North Shore Univ Hosp Great Neck New York 11021 —
Bellevue Hosp / New York Univ Med Ctr New York New York 10016 —
Metropolitan Hosp Ctr New York New York 10029 —
Harlem Hosp Ctr New York New York 10037 —
SUNY Health Sciences Ctr at Syracuse / Pediatrics Syracuse New York 13210 —
Bronx Lebanon Hosp Ctr The Bronx New York 10457 —
Bronx Municipal Hosp Ctr/Jacobi Med Ctr The Bronx New York 10461 —
Duke Univ Med Ctr Durham North Carolina 277103499 —
Med Univ of South Carolina Charleston South Carolina 294253312 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00001118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →